Menu
Recruiting NCT06391320

Obesity Queue Database

— Observational Obesity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: other.
Who it may be relevant to
Registry conditions: Obesity. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

To establish an obesity specific disease cohort database and form a special disease cohort, so as to provide guarantee for carrying out high-quality real-world clinical research and clinical research.

Interventions

  • Other other
    Observational studies do not involve intervention

Primary outcome measures

  • MRI-PDFF intraperitoneal fat content, fasting and postprandial blood glucose, insulin, C-peptide, glycated hemoglobin, body weight, waist circumference, hip circumference [Time frame: 5 years]
Secondary outcome measures (1)
  • Intestinal flora components, glucagon, gastrointestinal hormones GLP-1 and GIP, inflammatory immune indicators, etc [Time frame: 5 years]

Eligibility criteria

Inclusion criteria

  • Patients aged 18-75 years with simple obesity. Simple obesity diagnosis criteria: meet one of the following conditions
  • BMI≥25 kg/m2
  • Waist circumference for male/female ≥90/80 cm
  • Waist-to-hip ratio: 0.9 (male); 0.85 (female)

Exclusion criteria

  • Patients aged 18-75 years with simple obesity. Simple obesity diagnosis criteria: meet one of the following conditions
  • BMI≥25 kg/m2
  • Waist circumference for male/female ≥90/80 cm
  • Waist-to-hip ratio: 0.9 (male); 0.85 (female)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 1 center
  • Renji Hospital, Shanghai Jiao Tong University, School of Medicine — Shanghai

Identifiers

NCT: NCT06391320 · LY2023-212-B

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗